• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    What 4 Analyst Ratings Have To Say About Trupanion

    7/19/24 12:00:24 PM ET
    $TRUP
    Medical Specialities
    Health Care
    Get the next $TRUP alert in real time by email

    In the last three months, 4 analysts have published ratings on Trupanion (NASDAQ:TRUP), offering a diverse range of perspectives from bullish to bearish.

    The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

    Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
    Total Ratings 2 0 2 0 0
    Last 30D 0 0 0 0 0
    1M Ago 0 0 1 0 0
    2M Ago 0 0 0 0 0
    3M Ago 2 0 1 0 0

    The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $33.75, a high estimate of $49.00, and a low estimate of $22.00. This current average has increased by 8.0% from the previous average price target of $31.25.

    price target chart

    Exploring Analyst Ratings: An In-Depth Overview

    A clear picture of Trupanion's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

    Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
    John Barnidge Piper Sandler Raises Neutral $30.00 $22.00
    Joshua Shanker B of A Securities Raises Buy $49.00 $35.00
    Maria Ripps Canaccord Genuity Lowers Buy $34.00 $40.00
    John Barnidge Piper Sandler Lowers Neutral $22.00 $28.00

    Key Insights:

    • Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Trupanion. This offers insight into analysts' perspectives on the current state of the company.
    • Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Trupanion compared to the broader market.
    • Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Trupanion's stock. This comparison reveals trends in analysts' expectations over time.

    Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Trupanion's market standing. Stay informed and make well-considered decisions with our Ratings Table.

    Stay up to date on Trupanion analyst ratings.

    If you are interested in following small-cap stock news and performance you can start by tracking it here.

    Get to Know Trupanion Better

    Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.

    Trupanion's Financial Performance

    Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.

    Revenue Growth: Trupanion displayed positive results in 3 months. As of 31 March, 2024, the company achieved a solid revenue growth rate of approximately 19.43%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.

    Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -2.24%, the company may need to address challenges in effective cost control.

    Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -2.26%, the company may need to address challenges in generating satisfactory returns for shareholders.

    Return on Assets (ROA): Trupanion's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.87%, the company may face hurdles in achieving optimal financial performance.

    Debt Management: Trupanion's debt-to-equity ratio is below the industry average at 0.42, reflecting a lower dependency on debt financing and a more conservative financial approach.

    Analyst Ratings: What Are They?

    Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.

    Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

    If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $TRUP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TRUP

    DatePrice TargetRatingAnalyst
    8/13/2025$47.00Neutral
    Cantor Fitzgerald
    1/23/2025$57.00Neutral → Overweight
    Piper Sandler
    7/19/2024Outperform
    William Blair
    5/16/2024$35.00 → $49.00Neutral → Buy
    BofA Securities
    5/8/2023$72.00 → $32.00Buy → Neutral
    BofA Securities
    9/21/2022$77.00Buy
    Jefferies
    8/4/2022$80.00 → $69.00Overweight → Neutral
    Piper Sandler
    2/24/2022$129.00 → $118.00Neutral → Buy
    B of A Securities
    More analyst ratings

    $TRUP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Bearman Asher claimed ownership of 69,272 shares (SEC Form 3)

    3 - TRUPANION, INC. (0001371285) (Issuer)

    2/17/26 5:08:12 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Chief Operating Officer Gallagher John R sold $13,618 worth of shares (430 units at $31.67), decreasing direct ownership by 1% to 31,861 units (SEC Form 4)

    4 - TRUPANION, INC. (0001371285) (Issuer)

    1/29/26 6:57:35 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Director Low Murray B exercised 23,213 shares at a strike of $8.57, increasing direct ownership by 18% to 154,534 units (SEC Form 4)

    4 - TRUPANION, INC. (0001371285) (Issuer)

    1/12/26 8:44:15 PM ET
    $TRUP
    Medical Specialities
    Health Care

    $TRUP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Rawlings Darryl bought $499,663 worth of shares (20,700 units at $24.14), increasing direct ownership by 3% to 614,842 units (SEC Form 4) (Amendment)

    4/A - TRUPANION, INC. (0001371285) (Issuer)

    5/15/24 7:27:19 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Rawlings Darryl bought $499,663 worth of shares (20,700 units at $24.14), increasing direct ownership by 3% to 614,842 units (SEC Form 4)

    4 - TRUPANION, INC. (0001371285) (Issuer)

    5/9/24 6:40:58 PM ET
    $TRUP
    Medical Specialities
    Health Care

    $TRUP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Trupanion Reports Fourth Quarter & Full Year 2025 Results

    SEATTLE, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2025. "Since 2021, we've delivered more than $500 million in discretionary profit, growing at a 22% CAGR, including over $150 million last year alone," said Margi Tooth, Chief Executive Officer and President of Trupanion. "In 2025, we achieved our 15% annual margin target, while increasing subscription revenue and reinvesting record profits to drive four straight quarters of higher retention and accelerating gross pet adds. We're poised to advance confidently into our n

    2/12/26 4:05:00 PM ET
    $TRUP
    Medical Specialities
    Health Care

    25 Years of Paws and Protection: Trupanion Reflects on a Quarter-Century of Protecting Our Furry Best Friends

    From Canada to the U.S. and now Continental Europe, Trupanion has helped more than 3.8 million pet parents budget for the unexpected. SEATTLE, Jan. 27, 2026 /PRNewswire/ -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of pet medical insurance in North America, is celebrating its 25th anniversary - a milestone that reflects a legacy of transforming how pet parents around the world approach care for their four-legged family members. Over the past 25 years, Trupanion has evolved from a visionary startup into a global leader protecting more than one million pets today. As t

    1/27/26 11:30:00 AM ET
    $TRUP
    Medical Specialities
    Health Care

    Trupanion Announces Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2025 fourth quarter and full year after the market closes on Thursday, February 12, 2026. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site. P

    1/22/26 4:16:00 PM ET
    $TRUP
    Medical Specialities
    Health Care

    $TRUP
    SEC Filings

    View All

    SEC Form 10-K filed by Trupanion Inc.

    10-K - TRUPANION, INC. (0001371285) (Filer)

    2/13/26 4:07:14 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Trupanion Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - TRUPANION, INC. (0001371285) (Filer)

    2/12/26 4:01:50 PM ET
    $TRUP
    Medical Specialities
    Health Care

    SEC Form 144 filed by Trupanion Inc.

    144 - TRUPANION, INC. (0001371285) (Subject)

    12/29/25 4:01:33 PM ET
    $TRUP
    Medical Specialities
    Health Care

    $TRUP
    Leadership Updates

    Live Leadership Updates

    View All

    Grindr Appoints Veteran Public Company CFO and Audit Committee Chair Chad Cohen to Board of Directors

    Cohen to serve as Chair of the Audit Committee Grindr Inc. (NYSE:GRND), the Global Gayborhood in Your Pocket™, today announced the appointment of Chad Cohen, former Chief Financial Officer of Zillow Group Inc. (NASDAQ:Z) and Adaptive Biotechnologies Corp. (NASDAQ:ADPT) and Founding Partner of Scala Advisors, LLC, to Grindr's Board of Directors as of June 3, 2025. Cohen was also appointed to serve as the Chair of Grindr's Audit Committee. A seasoned public company finance executive and board member, Cohen has helped grow several multi-billion dollar technology companies, including multiple leading consumer Internet brands. Prior to his current role, Cohen served as the Chief Financial Of

    6/3/25 4:05:00 PM ET
    $ADPT
    $GRND
    $TRUP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Computer Software: Programming Data Processing
    Technology

    Trupanion Partners with Leading Pet and Public Health Authorities to Launch Pet & Public Health Early Warning and Detection System

    Boehringer Ingelheim, Mars Science & Diagnostics and leading pet, public health and animal health authorities to join Advisory Board Collaboration to address emerging pet and public health threats to protect pets and peopleEarly detection potential has global pet and public health benefits  SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs in North America, in partnership with the Centers for Disease Control and Prevention (CDC), and leading pet industry partners, today announced the formation of a collaborative Advisory Board to launch a Pet & Public Health Early Warning & Detection System. The Advisory B

    8/14/24 9:00:00 AM ET
    $TRUP
    Medical Specialities
    Health Care

    Trupanion's Margi Tooth Appointed Chief Executive Officer Effective August 1, 2024

    SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced that its Board of Directors has unanimously approved the appointment of Margi Tooth to Chief Executive Officer, effective August 1, 2024. Tooth's appointment to CEO marks the culmination of a multi-year, board-led process. Tooth will also continue as President and hold the dual titles of CEO and President. Additionally, Tooth is anticipated to be appointed to Trupanion's Board of Directors during its July meeting. Trupanion's founder and outgoing CEO Darryl Rawlings will continue to serve in the role of Chair of the Board, in which capacity he

    5/2/24 4:04:29 PM ET
    $TRUP
    Medical Specialities
    Health Care

    $TRUP
    Financials

    Live finance-specific insights

    View All

    Trupanion Reports Fourth Quarter & Full Year 2025 Results

    SEATTLE, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the fourth quarter and full year ended December 31, 2025. "Since 2021, we've delivered more than $500 million in discretionary profit, growing at a 22% CAGR, including over $150 million last year alone," said Margi Tooth, Chief Executive Officer and President of Trupanion. "In 2025, we achieved our 15% annual margin target, while increasing subscription revenue and reinvesting record profits to drive four straight quarters of higher retention and accelerating gross pet adds. We're poised to advance confidently into our n

    2/12/26 4:05:00 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Trupanion Announces Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2025 fourth quarter and full year after the market closes on Thursday, February 12, 2026. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site. P

    1/22/26 4:16:00 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Trupanion Reports Strong Third Quarter 2025 Results and Secures New Credit Facility

    SEATTLE, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the third quarter ended September 30, 2025. "We delivered record quarterly profitability while accelerating subscription pet growth for the third consecutive quarter," said Margi Tooth, Chief Executive Officer and President of Trupanion. "With a strong financial foundation, we have the flexibility to invest where it matters most - driving sustainable growth and expanding access to care. Our disciplined model continues to generate meaningful cash flow, positioning us to build on this momentum in the quarters ahead." Th

    11/6/25 4:05:00 PM ET
    $PNC
    $TRUP
    Major Banks
    Finance
    Medical Specialities
    Health Care

    $TRUP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Trupanion Inc.

    SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

    11/8/24 10:46:38 AM ET
    $TRUP
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Trupanion Inc. (Amendment)

    SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

    4/5/24 4:09:50 PM ET
    $TRUP
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Trupanion Inc. (Amendment)

    SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

    2/12/24 11:02:49 AM ET
    $TRUP
    Medical Specialities
    Health Care

    $TRUP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Trupanion with a new price target

    Cantor Fitzgerald initiated coverage of Trupanion with a rating of Neutral and set a new price target of $47.00

    8/13/25 8:15:02 AM ET
    $TRUP
    Medical Specialities
    Health Care

    Trupanion upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Trupanion from Neutral to Overweight and set a new price target of $57.00

    1/23/25 7:55:01 AM ET
    $TRUP
    Medical Specialities
    Health Care

    William Blair initiated coverage on Trupanion

    William Blair initiated coverage of Trupanion with a rating of Outperform

    7/19/24 7:44:19 AM ET
    $TRUP
    Medical Specialities
    Health Care